Takotsubo Syndrome During the COVID-19 Pandemic: State-of-the-Art Review

Gassan Moady, Shaul Atar

Research output: Contribution to journalReview articlepeer-review

18 Scopus citations


The current coronavirus disease 2019 (COVID-19) presents an ongoing medical challenge, as it involves multiple organs, including the cardiovascular system. Takotsubo syndrome (TTS) has been described in the context of COVID-19 in 2 different scenarios: as a direct complication of the infection, and as an indirect outcome secondary to the psychological burden of quarantine and social isolation (ie, stress-induced cardiomyopathy). Confirming the diagnosis of TTS in COVID-19 may be challenging due to the limited use of coronary angiography consistent with the recommended guidelines aimed at minimizing contact with infected individuals. The use of natriuretic peptide as a diagnostic and prognostic marker in this context may not be reliable as this peptide is already elevated in severe cases of COVID-19 regardless of TTS diagnosis. A relatively high incidence of complications has been reported in these cases, probably related to the severity of the underlying infectious disease. Although quarantine-induced stress cardiomyopathy is an unsurprising outcome of the powerful stress resulting from the current pandemic, conflicting results have been reported, and further studies are encouraged to determine the true incidence.

Original languageEnglish
Pages (from-to)1249-1256
Number of pages8
JournalCJC Open
Issue number10
StatePublished - Oct 2021

Bibliographical note

Publisher Copyright:
© 2021 The Authors


Dive into the research topics of 'Takotsubo Syndrome During the COVID-19 Pandemic: State-of-the-Art Review'. Together they form a unique fingerprint.

Cite this